Akers Biosciences Inc Current Ratio 2012-2019 | AKER

Akers Biosciences Inc current ratio from 2012 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Akers Biosciences Inc Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $0.00B $0.00B 3.14
2019-06-30 $0.01B $0.00B 3.25
2019-03-31 $0.01B $0.00B 2.87
2018-12-31 $0.01B $0.00B 3.38
2018-09-30 $0.01B $0.00B 3.44
2018-06-30 $0.01B $0.00B 5.71
2018-03-31 $0.01B $0.00B 8.09
2017-12-31 $0.01B $0.00B 4.36
2017-09-30 $0.00B $0.00B 2.35
2017-06-30 $0.01B $0.00B 3.15
2017-03-31 $0.01B $0.00B 3.92
2016-12-31 $0.00B $0.00B 1.88
2016-09-30 $0.00B $0.00B 2.94
2016-06-30 $0.00B $0.00B 2.51
2016-03-31 $0.01B $0.00B 3.13
2015-12-31 $0.01B $0.00B 3.88
2015-09-30 $0.01B $0.00B 6.57
2015-06-30 $0.01B $0.00B 8.48
2015-03-31 $0.01B $0.00B 10.26
2014-12-31 $0.01B $0.00B 7.08
2014-09-30 $0.01B $0.00B 14.32
2014-06-30 $0.02B $0.00B 15.69
2014-03-31 $0.02B $0.00B 16.08
2013-12-31 $0.00B $0.00B 2.05
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B $0.00B 1.17
2011-12-31 $0.00B $0.00B 3.66
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.002B $0.002B
Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company's products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in Thorofare, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $152.034B 27.73
Medtronic (MDT) Ireland $150.632B 20.81
Stryker (SYK) United States $74.735B 25.13
Boston Scientific (BSX) United States $62.262B 29.39
Baxter (BAX) United States $42.637B 25.85
Essilor Luxottica (ESLOY) France $33.791B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.320B 19.02
Terumo (TRUMY) Japan $26.378B 32.92
Lonza Group Ag (LZAGY) Switzerland $25.349B 0.00
Coloplast (CLPBY) Denmark $25.034B 38.63
ResMed (RMD) United States $21.891B 40.38
Smith & Nephew SNATS (SNN) United Kingdom $19.633B 0.00
Sunny Optical Technology (SNPTF) China $19.217B 0.00
Bio-Rad Laboratories (BIO) United States $10.857B 52.11
Insulet (PODD) United States $10.712B 509.65
William Demant Holdings (WILYY) Denmark $7.626B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
Perrigo (PRGO) Ireland $7.422B 13.84
Canopy Growth (CGC) Canada $7.365B 0.00
Hill-Rom Holdings (HRC) United States $7.342B 21.65
Haemonetics (HAE) United States $5.938B 40.13
Shandong Weigao Medical Polymer (SHWGF) China $5.472B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.844B 30.27
ICU Medical (ICUI) United States $3.765B 24.54
Neogen (NEOG) United States $3.625B 60.65
GW Pharmaceuticals (GWPH) United Kingdom $3.265B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.174B 0.00
Quidel (QDEL) United States $2.995B 28.42
Aurora Cannabis (ACB) Canada $2.833B 0.00
Agios Pharmaceuticals (AGIO) United States $2.691B 0.00
National Vision Holdings (EYE) United States $2.513B 56.71
Cardiovascular Systems (CSII) United States $1.557B 0.00
Aphria (APHA) $1.326B 0.00
InMode (INMD) Israel $1.245B 0.00
AtriCure (ATRC) United States $1.217B 0.00
VAREX IMAGING (VREX) United States $1.208B 24.20
Phibro Animal Health (PAHC) United States $0.994B 18.61
TG Therapeutics (TGTX) United States $0.935B 0.00
NanoString Technologies (NSTG) United States $0.916B 0.00
Lantheus Holdings (LNTH) United States $0.810B 20.23
Eagle Pharmaceuticals (EGRX) United States $0.809B 30.96
LeMaitre Vascular (LMAT) United States $0.707B 39.75
Quanterix (QTRX) United States $0.698B 0.00
PetIQ (PETQ) United States $0.694B 16.94
Omeros (OMER) United States $0.657B 0.00
HEXO (HEXO) $0.573B 0.00
Cerus (CERS) United States $0.566B 0.00
Surmodics (SRDX) United States $0.549B 57.11
MacroGenics (MGNX) United States $0.505B 0.00
OraSure Technologies (OSUR) United States $0.491B 29.48
Meridian Bioscience (VIVO) United States $0.418B 14.38
Organigram Holdings (OGI) Canada $0.401B 0.00
Utah Medical Products (UTMD) United States $0.395B 28.63
Owens & Minor (OMI) United States $0.387B 14.30
BioLife Solutions (BLFS) United States $0.317B 129.08
Zynex (ZYXI) United States $0.283B 32.04
Neptune Wellness Solutions (NEPT) Canada $0.281B 0.00
Bovie Medical (APYX) United States $0.275B 0.00
United Health Products (UEEC) United States $0.254B 0.00
Vapotherm (VAPO) United States $0.245B 0.00
Viemed Healthcare (VMD) United States $0.239B 25.14
Repro-Med Systems (KRMD) United States $0.234B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.170B 0.00
Liberty Health Sciences (LHSIF) Canada $0.170B 0.00
InfuSystems Holdings (INFU) United States $0.164B 824.00
Female Health (VERU) United States $0.156B 0.00
Rockwell Medical (RMTI) United States $0.145B 0.00
MTech Acquisition (KERN) United States $0.136B 0.00
Fonar (FONR) United States $0.131B 9.20
Cytosorbents (CTSO) United States $0.130B 0.00
Chimerix (CMRX) United States $0.118B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
United-Guardian (UG) United States $0.091B 23.03
Chembio Diagnostics (CEMI) United States $0.078B 0.00
Nephros (NEPH) United States $0.067B 0.00
MRI Interventions (MRIC) United States $0.062B 0.00
Surface Oncology (SURF) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.015B 0.00
GUARDION HEALTH (GHSI) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00